Origin, a women’s health platform providing physical therapy and expert guidance for issues specific to the female body, today announces aggressive growth plans following a seed funding round led by Brand Foundry Ventures and The Blue Venture Fund. The new investment will be used to accelerate Origin’s mission of ensuring women and mothers nationwide in the U.S. have access to specialized, expert…
Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your…
Israeli femtech company MobileODT, who are innovating in cervical cancer screening, have announced that their Visual Check AI technology is supporting a large-scale government cervical cancer screening project in the Dominican Republic. This proof of concept project was initiated as part of the company’s strategic direction in providing cervical cancer screening at scale, utilizing Artificial Intelligence (AI) and Machine Learning (ML) capabilities. The…
Natera, a global leader in non-invasive genetic testing and analysis of cfDNA, and Tesis Labs, a US multi-region lab services provider with labs in Colorado, Texas and Arizona, announced a strategic partnership in the field of prenatal genetic testing. The collaboration will allow Tesis to broaden its portfolio of genetic testing offerings and participate in the fast growing screening market for over 4 million pregnancies in the…
Cleo, a leading family benefits platform supporting working families in the planning stage through the teenage years, today announced a $40 million Series C investment led by Transformation Capital, with participation from Glynn Capital, PruVen Capital and Gaingels and existing investors Greylock, NEA and Felicis. In conjunction with this round, Transformation Capital Managing Partner, Mike Dixon will join Cleo’s Board. This round…
Healthcare startup Béa Fertility has announced a £800K raise to bring a pioneering at-home fertility treatment to the UK. The round was led by Calm/Storm VC and joined by Q Ventures, and includes an innovation grant from the recent InnovateUK SMART competition. Founded by embryologist David O’Rourke and femtech specialist Tess Cosad, Béa Fertility is focused on democratising access to affordable, effective…
Women’s and Family Health Startup Maven has announced the expansion of its award-winning fertility program with the launch of MavenRx. Through partnerships with two specialty pharmacies, Maven members can now receive industry-leading price discounts on their medications, complimentary same-day or next-day shipping nationwide, and on-demand, pharmacist-led unboxing and injection support. MavenRx adds a critical layer of support for all U.S.-based employees covered…
The knock-on effects of the pandemic that disrupted our lives in 2020 are still prevalent, despite the hopeful wishes of a “Happy New Year”. These disruptions, in particular, have affected those looking to plan a family. With many wedding plans postponed, dating lives interrupted or halted altogether, family plans have also been affected. Studies have shown that 6 in 10 women are anxious…
